Author(s): Marigona Bytyqi, Driton Shabani, Adnan Bozalija

Email(s): adnan.bozalija@uni-pr.edu

DOI: 10.52711/0974-360X.2022.00624   

Address: Marigona Bytyqi1, Driton Shabani2, Adnan Bozalija1*
1Department of Drug Analysis and Pharmaceutical Technology, Pharmacy Branch, Faculty of Medicine, University of Prishtina, Prishtina 10000, Kosovo.
2Department of Pharmaceutical Chemistry and Chemical Toxicology, Pharmacy Branch, Faculty of Medicine, University of Prishtina, Prishtina 10000, Kosovo.
*Corresponding Author

Published In:   Volume - 15,      Issue - 8,     Year - 2022


ABSTRACT:
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that possesses anti-inflammatory, analgesic, and antipyretic effects and it is widely manufactured and marketed in the Republic of Kosovo. The study aims to evaluate the in vitro quality of three ibuprofen uncoated tablets 400mg formulations that are commercially most commonly used in the Republic of Kosovo markets. Ibuprofen tablets were tested for the uniformity of weight, disintegration time, friability, and analysis of the drug active content with the UV spectrophotometric and high-performance liquid chromatography (HPLC) method following comparisons with official protocols and pharmacopeia monograph. The weight uniformity testing and weight variation indicated no significant changes in the weight and variation among the analyzed brands' tablets. The friability values were <1 % and the disintegration times were between 3.87 and 10.01 min, which showed significantly variation for the first brand but all the samples meet official requirements (within 15 min for uncoated tablets). In addition, the results of the assay of chemical content using UV-VIS and HPLC analysis meet the official specification in the UV and HPLC assay methods (95-105% of active drug content). Our data indicated that the Ibuprofen tablet investigated in our study meets the in vitro quality control meets the official specifications, is chemically equivalent, and does not vary in physiochemical qualities.


Cite this article:
Marigona Bytyqi, Driton Shabani, Adnan Bozalija. In vitro Pharmaceutical Quality Evaluation of different Ibuprofen tablet brands available on the Republic of Kosovo Market. Research Journal of Pharmacy and Technology. 2022; 15(8):3725-0. doi: 10.52711/0974-360X.2022.00624

Cite(Electronic):
Marigona Bytyqi, Driton Shabani, Adnan Bozalija. In vitro Pharmaceutical Quality Evaluation of different Ibuprofen tablet brands available on the Republic of Kosovo Market. Research Journal of Pharmacy and Technology. 2022; 15(8):3725-0. doi: 10.52711/0974-360X.2022.00624   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-8-66


REFERENCES:
1.    Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009; 17(6):275-342.doi.org/10.1007/s10787-009-0016-x
2.    Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman Medical Journal. 2010; 25(3):155.doi.org/ 10.5001/omj.2010.49
3.    Mazaleuskaya LL, Theken KN, Gong L, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015; 25(2):96.doi.org/ 10.1097/FPC.0000000000000113
4.    Bookstaver PB, Miller AD, Rudisill CN, Norris LB. Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. Journal Pain Research. 2010; 3:67.doi.org/10.2147/jpr.s6993.
5.    Rainsford KD, editor. Ibuprofen: A critical bibliographic review. 2003; 1-528.
6.    Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Advance Therapeutics. 2020; 37(1):61-82.doi.org/10.1007/s12325-019-01144-9.
7.    Solomon DH, Husni ME, Libby PA, Yeomans ND, Lincoff AM, Lϋscher TF, Menon V, Brennan DM, Wisniewski LM, Nissen SE, Borer JS. The risk of major NSAID toxicity with celecoxib, ibuprofen, or naproxen: a secondary analysis of the PRECISION trial. The American Journal of Medicine. 2017; 130(12):1415-22.doi.org/10.1016/j.amjmed.2017.06.028
8.    Görög S. Drug safety, drug quality, drug analysis. Journal of Pharmaceutical Biomed Analysis. 2008; 48(2):247-53.doi.org/ 10.1016/j.jpba.2007.10.038
9.    Höllein L, Kaale E, Mwalwisi YH, Schulze MH, Holzgrabe U. Routine quality control of medicines in developing countries: analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania. Trends Analyt Chemistry. 2016; 76: 60-70.doi.org/10.1016/j.trac.2015.11.009
10.    Galgatte UC, Jamdade VR, Aute PP, Chaudhari PD. Study on requirements of bioequivalence for registration of pharmaceutical products in USA, Europe and Canada. Saudi Pharm Journal. 2016; 22(5):391-402.doi.org/10.1016/j.jsps.2013.05.001
11.    World Health Organization. Quality assurance of pharmaceuticals: A compendium of guidelines and related materials. Good manufacturing practices and inspection. World Health Organization. 2007; vol 1.
12.    Hoti E, Noga F, Tafa A, Myftari E. RP˗ HPLC a valuable tool in monitoring dissolution test of fixed combination dosage forms. Macedonian Pharmaceutical Buletin. 2000; 66 (S1):153-54.doi.org/10.33320/maced.pharm.bull.2020.66.03.076
13.    Berisha A, Baxhaku B, Sheqerxhiu N, Hoxha A, Orqusha N, Mehmeti V, Hashani I, Halili J, Jusufi K, Thaçi V, Halili A. The evaluation of the short-term photostability of the alprazolam drug. Radiation&Applications. 2017; 2(1):71-4.doi.or/10.21175/RadJ.2017.01.016
14.    Imasheva, Aizhan; Seiter, Andreas. 2008. The Pharmaceutical Sector of the Western Balkan Countries. HNP discussion paper series;. World Bank, Washington, DC. © World Bank. https://openknowledge.worldbank.org/handle/10986/13736 License:
15.    Sultana S, Hosen MS. In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka, Bangladesh. BMC Research Notes. 2018; 11(1):1-5.doi.org/10.1186/s13104-018-3285-x
16.    Khuluza F. In-vitro evaluation of the quality of Paracetamol and Co-trimoxazole tablets used in Malawi based on pharmacopoeial standards. Malawi Medical Journal. 2014;26(2):38-41.
17.    World Health Organization. WHO good practices for pharmaceutical quality control laboratories. WHO Technical Report Series. 2010; 957.
18.    Giri TK, Sahu R, Kumar K, Alexander A, Badwaik H, Tripathi DK. In-vitro quality control measurement of some commercially available sustained release tablet containing diclofenac sodium. Research Journal of Pharmacy and Technology. 2012; 5(5):687-90.
19.    Sri KV, Anusha M, Reddy SR. A Rapid RP-HPLC Method development and Validation for the Analysis of Linagliptinin Bulk and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2015; 5(1):16-20.doi.org/10.5958/2231-5675.2015.00003.4
20.    Chabukswar AR, Thakur VG, Dharam DL, Shah MH, Kuchekar BS, Sharma SN. Development and validation of HPTLC method for simultaneous estimation of paracetamol, ibuprofen and caffeine in bulk and pharmaceutical dosage form. Research Journal of Pharmacy and Technology. 2012; 5(9):1218-22.
21.    Dhingra G, Sreelesh B, Nagpal M, Rakha P, Nagori BP. In-Vitro Dissolution Testing of Ibuprofen Using Compendial and Biorelevant Dissolution Media. Research Journal of Pharmacy and Technology. 2010; 3(3):931-3.
22.    Thu NA. Quantification of acetaminophen, caffeine and ibuprofen in solid dosage forms by uv spectroscopy coupled with multivariate analysis. Asian Journal of Pharmaceutical Analysis,. 2021; 11(2):127-32.doi.org/10.52711/2231-5675.2021.00022
23.    Jadhav AP, Datar PA, Kedar TR, Kardile DP, Shete RV. Analytical method development and validation of thiocolchicoside and ibuprofen in tablet dosage form by UV-Spectrophotometry method. Research Journal of Pharmacy and Technology. 2021;14(2):981-5. doi.org/ 10.5958/0974-360X.2021.00175.X
24.    Eraga SO, Arhewoh MI, Chibuogwu RN, Iwuagwu MA. A comparative UV− HPLC analysis of ten brands of ibuprofen tablets. Asian Pacific Journal Tropical Biomedicine. 2015; 5(10):880-4.doi.org/10.1016/j.apjtb.2015.06.005
25.    Gwaziwa NN, Dzomba P, Mupa M. A quality control study of ibuprofen tablets available in the formal and informal market in Harare, Zimbabwe. African Journal of Pharmacy and Pharmacology. 2017; 11(16):195-203.doi.org/10.5897/AJPP2017.4746
26.    Dewan SM, Alam A, Ahamed SK. A comparative quality control study on conventional ibuprofen tablets available in Bangladeshi pharma market. Int Res. J Pharm. 2013; 4(1):96-8.
27.    Eichie FE, Arhewoh IM, Ezeobi OC. In-vitro evaluation of the pharmaceutical quality of some ibuprofen tablets dispensed in Nigeria. African Journal Pharmacy and Pharmacology. 2009; 3(10):491-5.doi.org/10.5897/AJPP.9000187
28.    Popa DE, Lupuliasa D, Stanescu AA, Barca M, Dragomiroiu GT, Miron DS, Radulescu FS. Simulation of the in vivo exposure to ibuprofen based on in vitro dissolution profiles from solid dosage forms. FARMACIA. 2014; 62(3):475-85.
29.    Gupta MM. Quality control testing of different brands of conventional tablets of ibuprofen available in Trinidad & Tobago, West Indies: An in-vitro testing. InFaculty of Medical Sciences, Research Day 2019.
30.    Welegebrial BG, Kahsay G, Eticha T, Gebretsadik H. Comparative In Vitro Quality Evaluation of Different Brands of Ibuprofen Tablets Marketed in Mekelle, Ethiopia. ResearchSquare. 2020; 1-12. doi.org/10.21203/rs.3.rs-25674/v2
31.    Moorthy U, Sunil J, Nath MS. HPLC Method development and validation for simultaneous estimation of ibuprofen and pseudoephedrine in pharmaceutical dosage forms. Asian Journal of Research in Chemistry. 2010; 3(4):859-61.
32.    Zambakjian C, Sakur AA. New Validated Gas Chromatographic Method for the Simultaneous Determination of Ibuprofen and Paracetamol in Bulk and Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology; 2020; 13(11):5103-7.doi.org/ 10.5958/0974-360X.2020.00893.8
33.    Panchale WA, Suroshe R, Rathod MS, Pandhare YL. Chromatographic analysis of famotidine, paracetamol and ibuprofen from tablet formulation. Research Journal of Pharmacy and Technology. 2019; 12(1):231-6.doi.org/10.5958/0974-360X.2019.00043.X
34.    Paul S, Sun CC. Dependence of friability on tablet mechanical properties and a predictive approach for binary mixtures. Pharmaceutical Research. 2017; 34(12):2901-9.doi.org/10.1007/s11095-017-2273-5
35.    Green G, Berg C, Polli J, Barends D. Pharmacopeial standards for the subdivision characteristics of scored tablets. InPharmacopeial Forum. 2009; 35(6):1598-1612.doi.org/10.13140/2.1.4057.6807
36.    Van Santen E, Barends DM, Frijlink HW. Breaking of scored tablets: a review. European Journal of Pharmaceutics and Biopharmaceutics. 2002; 53(2):139-45.doi.org/10.1016/s0939-6411(01)00228-4
37.    Bulduk İ. HPLC-UV method for quantification of favipiravir in pharmaceutical formulations. Acta Chromatographica. 2021; 33(3):209-15.doi.org/10.1556/1326.2020.00828
38.    Gungor S, Bulduk I, Sultan Aydın B, Ilikci Sagkan R. A comparative study of HPLC and UV spectrophotometric methods for oseltamivir quantification in pharmaceutical formulations. Acta Chromatographica. 2021. doi.org/10.1556/1326.2021.00925
39.    Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health policy. 2011; 99(2):139-48.doi.org/10.1016/j.healthpol.2010.08.002
40.    World Health Organization, Mehta, Dinesh K, Ryan, Rachel & Hogerzeil, Hans V. (‎2004)‎. WHO model formulary 2004 / editors: Dinesh K. Mehta, Rachel Ryan, Hans V. Hogerzeil. World Health Organization. https://apps.who.int/iris/handle/10665/42797
41.    Glerum PJ, Neef C, Burger DM, Yu Y, Maliepaard M. Pharmacokinetics and Generic Drug Switching: A Regulator’s View. Clinical Pharmacokinetics. 2020; 59(9):1065-9.doi.org/10.1007/s40262-020-00909-8
42.    Hammami MM, De Padua SJ, Hussein R, Al Gaai E, Khodr NA, Al-Swayeh R, Alvi SN, Binhashim N. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs. BMC Pharmacology and Toxicology. 2017; 18(1):1-20.doi.org/10.1186/s40360-017-0182-1
43.    Al-Dalaen SM, Hamad AW, AL-Hujran TA, Al-Btoush HA, Al-Halaseh L, Magharbeh MK. Bioavailability and Bioequivalence of Two Oral Single Dose of Ibuprofen 400 mg to Healthy Volunteers. Biomedical and Pharmacology Journal. 2021; 30;14(1):435-44. doi.org/10.13005/bpj/2143
44.    British Pharmacopoeia Commission. British Pharmacopoaeia Vol.I. London: The Stationery Office Limited. 2011: p. 1110.
45.    Radi M, Ramli Y, El Karbane M, Elalami A, Karrouchi K, Bekkali A, Benaji B, Issmaili S, Bakhous K. Optimization and validation of a method for determination of ibuprofen by HPLC in different pharmaceutical forms: Tablet, syrup, gel and suppository. Journal Chemical Pharmaceutical Research. 2014; 6(8):301-4.
46.    Jain A, Agarwal P, Kumawat A, Rammularjsinh R, Gautam H. Evaluation and validated uv-spectroscopic method for estimation of ibuprofen from marketed tablets (brufen400). Research Journal of Pharmacy and Technology. 2011; 4(4):620-3.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available